chr10-6479019-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_006257.5(PRKCQ):c.1326G>A(p.Thr442=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00928 in 1,614,094 control chromosomes in the GnomAD database, including 93 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0082 ( 8 hom., cov: 32)
Exomes 𝑓: 0.0094 ( 85 hom. )
Consequence
PRKCQ
NM_006257.5 synonymous
NM_006257.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.64
Genes affected
PRKCQ (HGNC:9410): (protein kinase C theta) Protein kinase C (PKC) is a family of serine- and threonine-specific protein kinases that can be activated by calcium and the second messenger diacylglycerol. PKC family members phosphorylate a wide variety of protein targets and are known to be involved in diverse cellular signaling pathways. PKC family members also serve as major receptors for phorbol esters, a class of tumor promoters. Each member of the PKC family has a specific expression profile and is believed to play a distinct role. The protein encoded by this gene is one of the PKC family members. It is a calcium-independent and phospholipid-dependent protein kinase. This kinase is important for T-cell activation. It is required for the activation of the transcription factors NF-kappaB and AP-1, and may link the T cell receptor (TCR) signaling complex to the activation of the transcription factors. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.62).
BP6
Variant 10-6479019-C-T is Benign according to our data. Variant chr10-6479019-C-T is described in ClinVar as [Benign]. Clinvar id is 784651.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.64 with no splicing effect.
BS2
High AC in GnomAd4 at 1246 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRKCQ | NM_006257.5 | c.1326G>A | p.Thr442= | synonymous_variant | 12/18 | ENST00000263125.10 | NP_006248.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRKCQ | ENST00000263125.10 | c.1326G>A | p.Thr442= | synonymous_variant | 12/18 | 1 | NM_006257.5 | ENSP00000263125 | P1 | |
PRKCQ | ENST00000397176.6 | c.1326G>A | p.Thr442= | synonymous_variant | 12/17 | 5 | ENSP00000380361 | |||
PRKCQ | ENST00000539722.5 | c.951G>A | p.Thr317= | synonymous_variant | 11/17 | 2 | ENSP00000441752 |
Frequencies
GnomAD3 genomes AF: 0.00820 AC: 1247AN: 152128Hom.: 8 Cov.: 32
GnomAD3 genomes
AF:
AC:
1247
AN:
152128
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00883 AC: 2219AN: 251316Hom.: 17 AF XY: 0.00881 AC XY: 1197AN XY: 135818
GnomAD3 exomes
AF:
AC:
2219
AN:
251316
Hom.:
AF XY:
AC XY:
1197
AN XY:
135818
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00939 AC: 13727AN: 1461848Hom.: 85 Cov.: 31 AF XY: 0.00930 AC XY: 6763AN XY: 727220
GnomAD4 exome
AF:
AC:
13727
AN:
1461848
Hom.:
Cov.:
31
AF XY:
AC XY:
6763
AN XY:
727220
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00818 AC: 1246AN: 152246Hom.: 8 Cov.: 32 AF XY: 0.00814 AC XY: 606AN XY: 74438
GnomAD4 genome
AF:
AC:
1246
AN:
152246
Hom.:
Cov.:
32
AF XY:
AC XY:
606
AN XY:
74438
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
12
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 12, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at